GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (STU:4RY) » Definitions » Buildings And Improvements

Akeso (STU:4RY) Buildings And Improvements : €189.6 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Akeso Buildings And Improvements?

Akeso's quarterly buildings and improvements declined from Dec. 2023 (€110.9 Mil) to Jun. 2024 (€0.0 Mil) but then increased from Jun. 2024 (€0.0 Mil) to Dec. 2024 (€189.6 Mil).

Akeso's annual buildings and improvements increased from Dec. 2022 (€90.0 Mil) to Dec. 2023 (€110.9 Mil) and increased from Dec. 2023 (€110.9 Mil) to Dec. 2024 (€189.6 Mil).


Akeso Buildings And Improvements Historical Data

The historical data trend for Akeso's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akeso Buildings And Improvements Chart

Akeso Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buildings And Improvements
Get a 7-Day Free Trial 10.65 56.57 89.98 110.89 189.56

Akeso Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.98 - 110.89 - 189.56

Akeso Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


Akeso Business Description

Industry
Traded in Other Exchanges
Address
No. 6, Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in Mainland China, and also has its presence in USA and Other regions.

Akeso Headlines

No Headlines